Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | $21.44 | $1.59 B | -7.1 | 58 | $0 | ||
Alector, Inc. | $4.41 | $420.24 M | -3.14 | 244 | $97.06 M | ||
Annexon, Inc. | $4.50 | $523.15 M | -3.93 | 70 | $0 | ||
Apellis Pharmaceuticals, Inc. | $36.26 | $4.90 B | -11.77 | 702 | $396.59 M | ||
Arrowhead Pharmaceuticals, Inc. | $25.56 | $2.97 B | -5.65 | 525 | $240.74 M | ||
bluebird bio, Inc. | $0.92 | $174.43 M | -1.44 | 323 | $3.60 M | ||
Blueprint Medicines Corporation | $111.64 | $6.47 B | -21.48 | 645 | $249.38 M | ||
Cabaletta Bio, Inc. | $7.03 | $508.83 M | -6.16 | 118 | $0 | ||
Cytokinetics, Incorporated | $55.45 | $6.05 B | -9.78 | 423 | $7.53 M | ||
Day One Biopharmaceuticals, Inc. | $13.71 | $1.12 B | -5.11 | 174 | $0 | ||
Editas Medicine, Inc. | $4.58 | $435.86 M | -2.56 | 265 | $78.12 M | ||
Inozyme Pharma, Inc. | $4.49 | $286.39 M | -3.43 | 59 | $0 | ||
Mersana Therapeutics, Inc. | $1.83 | $261.85 M | -1.91 | 123 | $36.86 M | ||
ProQR Therapeutics N.V. | $1.71 | $151.08 M | -5.14 | 156 | $6.38 M | ||
Protagonist Therapeutics, Inc. | $33.71 | $2.04 B | 13.7 | 124 | $60.00 M | ||
Relay Therapeutics, Inc. | $6.37 | $1.05 B | -3 | 309 | $25.55 M | ||
Revolution Medicines, Inc. | $37.53 | $6.66 B | -10.51 | 411 | $11.58 M | ||
Syndax Pharmaceuticals, Inc. | $20.93 | $1.66 B | -6.02 | 184 | $0 | ||
Stoke Therapeutics, Inc. | $13.12 | $774.50 M | -6.14 | 110 | $8.78 M | ||
Terns Pharmaceuticals, Inc. | $6.82 | $462.44 M | -5.67 | 66 | $0 | ||
Travere Therapeutics, Inc. | $7.90 | $542.80 M | -1.32 | 380 | $145.24 M | ||
Y-mAbs Therapeutics, Inc. | $11.38 | $525.71 M | -24.45 | 100 | $84.82 M | ||
Zentalis Pharmaceuticals, Inc. | $3.63 | $754.16 M | -3.26 | 124 | $0 |